Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia

Detalles Bibliográficos
Autores principales: Hengeveld, P. J., Schilperoord-Vermeulen, J., van der Klift, M. Y., Dubois, J. M. N., Kolijn, P. M., Kavelaars, F. G., Rijken, M., Dobber, J. A., Nasserinejad, K., Kersting, S., Westerweel, P. E., Kater, A. P., Langerak, A. W., Levin, M-D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317999/
https://www.ncbi.nlm.nih.gov/pubmed/37400508
http://dx.doi.org/10.1038/s41408-023-00870-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317999/
https://www.ncbi.nlm.nih.gov/pubmed/37400508
http://dx.doi.org/10.1038/s41408-023-00870-2

Ejemplares similares